Xanthine oxidoreductase-catalyzed reactive species generation: A process in critical need of reevaluation

Redox Biology

Volumn 1, Issue 1, 2013, Pages 353-358

  Cantu Medellin, Nadiezhda ^a   Kelley, Eric E ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Free radicals; Hypoxia; Inflammation; Nitric oxide; Nitrite; Oxygen tension; Xanthine oxidoreductase

Indexed keywords

FREE RADICAL; NITRATE REDUCTASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE REDUCTASE; OXIDIZING AGENT; XANTHINE OXIDASE; REACTIVE OXYGEN METABOLITE; XANTHINE DEHYDROGENASE;

CATALYSIS; DISEASE COURSE; ENZYME ACTIVITY; HUMAN; HYPOXIA; INFLAMMATION; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; ANIMAL; BIOCATALYSIS; METABOLISM;

ANIMALS; BIOCATALYSIS; FREE RADICALS; HUMANS; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; XANTHINE DEHYDROGENASE;

EID: 84880671877     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2013.05.002     Document Type: Review

References (53)

1. Enroth C., Eger B.T., Okamoto K., Nishino T., Nishino T., Pai E.F. Crystal structures of bovine milk xanthine dehydrogenase and xanthine oxidase: structure-based mechanism of conversion. Proceedings of the National Academy of Sciences USA 2000, 97:10723-10728.
2. Nishino T., Okamoto K. The role of the [2Fe-2s] cluster centers in xanthine oxidoreductase. Journal of Inorganic Biochemistry 2000, 82:43-49.
3. Iwasaki T., Okamoto K., Nishino T., Mizushima J., Hori H. Sequence motif-specific assignment of two [2Fe-2S] clusters in rat xanthine oxidoreductase studied by site-directed mutagenesis. Journal of Biochemistry 2000, 127:771-778.
4. Kuwabara Y., Nishino T., Okamoto K., Matsumura T., Eger B.T., Pai E.F., Nishino T. Unique amino acids cluster for switching from the dehydrogenase to oxidase form of xanthine oxidoreductase. Proceedings of the National Academy of Sciences USA 2003, 100:8170-8175.
5. Harris C.M., Massey V. The oxidative half-reaction of xanthine dehydrogenase with NAD; reaction kinetics and steady-state mechanism. Journal of Biological Chemistry 1997, 272:28335-28341.
6. Granger D.N., Rutili G., McCord J.M. Superoxide radicals in feline intestinal ischemia. Gastroenterology 1981, 81:22-29.
7. McCord J.M., Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). Journal of Biological Chemistry 1969, 244:6049-6055.
8. Fridovich I. Quantitative aspects of the production of superoxide anion radical by milk xanthine oxidase. Journal of Biological Chemistry 1970, 245:4053-4057.
9. Kelley E.E., Khoo N.K., Hundley N.J., Malik U.Z., Freeman B.A., Tarpey M.M. Hydrogen peroxide is the major oxidant product of xanthine oxidase. Free Radical Biology & Medicine 2010, 48:493-498.
10. Lartigue-Mattei C., Chabard J.L., Bargnoux H., Petit J., Berger J.A., Ristori J.M., Bussiere J.L., Catilina P., Catilina M.J. Plasma and blood assay of xanthine and hypoxanthine by gas chromatography-mass spectrometry: physiological variations in humans. Journal of Chromatography 1990, 529:93-101.
11. Pesonen E.J., Linder N., Raivio K.O., Sarnesto A., Lapatto R., Hockerstedt K., Makisalo H., Andersson S. Circulating xanthine oxidase and neutrophil activation during human liver transplantation. Gastroenterology 1998, 114:1009-1015.
12. Quinlan G.J., Lamb N.J., Tilley R., Evans T.W., Gutteridge J.M. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. American Journal of Respiratory and Critical Care Medicine 1997, 155:479-484.
13. Aslan M., Freeman B.A. Oxidant-mediated impairment of nitric oxide signaling in sickle cell disease-mechanisms and consequences. Cellular and Molecular Biology (Noisy.-le-grand) 2004, 50:95-105.
14. Aslan M., Ryan T.M., Adler B., Townes T.M., Parks D.A., Thompson J.A., Tousson A., Gladwin M.T., Patel R.P., Tarpey M.M., Batinic-Haberle I., White C.R., Freeman B.A. Oxygen radical inhibition of nitric oxide-dependent vascular function in sickle cell disease. Proceedings of the National Academy of Sciences USA 2001, 98:15215-15220.
15. White C.R., Darley-Usmar V., Berrington W.R., McAdams M., Gore J.Z., Thompson J.A., Parks D.A., Tarpey M.M., Freeman B.A. Circulating plasma xanthine oxidase contributes to vascular dysfunction in hypercholesterolemic rabbits. Proceedings of the National Academy of Sciences USA 1996, 93:8745-8749.
16. Harris C.M., Massey V. The reaction of reduced xanthine dehydrogenase with molecular oxygen. Reaction kinetics and measurement of superoxide radical. Journal of Biological Chemistry 1997, 272:8370-8379.
17. Zhou L., Stanley W.C., Saidel G.M., Yu X., Cabrera M.E. Regulation of lactate production at the onset of ischaemia is independent of mitochondrial NADH/NAD+: insights from in silico studies. Journal of Physiology 2005, 569:925-937.
18. Harrison R. Structure and function of xanthine oxidoreductase: where are we now?. Free Radical Biology & Medicine 2002, 33:774-797.
19. Kelley E.E., Hock T., Khoo N.K., Richardson G.R., Johnson K.K., Powell P.C., Giles G.I., Agarwal A., Lancaster J.R., Tarpey M.M. Moderate hypoxia induces xanthine oxidoreductase activity in arterial endothelial cells. Free Radical Biology & Medicine 2006, 40:952-959.
20. Parks D.A., Williams T.K., Beckman J.S. Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation. American Journal of Physiology 1988, 254:G768-G774.
21. Houston M., Estevez A., Chumley P., Aslan M., Marklund S., Parks D.A., Freeman B.A. Binding of xanthine oxidase to vascular endothelium. Kinetic characterization and oxidative impairment of nitric oxide-dependent signaling. Journal of Biological Chemistry 1999, 274:4985-4994.
22. Granell S., Gironella M., Bulbena O., Panes J., Mauri M., Sabater L., Aparisi L., Gelpi E., Closa D. Heparin mobilizes xanthine oxidase and induces lung inflammation in acute pancreatitis. Critical Care Medicine 2003, 31:525-530.
23. Landmesser U., Spiekermann S., Dikalov S., Tatge H., Wilke R., Kohler C., Harrison D.G., Hornig B., Drexler H. Vascular oxidative stress and endothelial dysfunction in patients with chronic heart failure: role of xanthine-oxidase and extracellular superoxide dismutase. Circulation 2002, 106:3073-3078.
24. Fukushima T., Adachi T., Hirano K. The heparin-binding site of human xanthine oxidase. Biological & Pharmaceutical Bulletin 1995, 18:156-158.
25. Adachi T., Fukushima T., Usami Y., Hirano K. Binding of human xanthine oxidase to sulphated glycosaminoglycans on the endothelial-cell surface. Biochemical Journal 1993, 289:523-527.
26. Kelley E.E., Trostchansky A., Rubbo H., Freeman B.A., Radi R., Tarpey M.M. Binding of xanthine oxidase to glycosaminoglycans limits inhibition by oxypurinol. Journal of Biological Chemistry 2004, 279:37231-37234.
27. Butler R., Morris A.D., Belch J.J., Hill A., Struthers A.D. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000, 35:746-751.
28. Desco M.C., Asensi M., Marquez R., Martinez-Valls J., Vento M., Pallardo F.V., Sastre J., Vina J. Xanthine oxidase is involved in free radical production in type 1 diabetes: protection by allopurinol. Diabetes 2002, 51:1118-1124.
29. Farquharson C.A., Butler R., Hill A., Belch J.J., Struthers A.D. Allopurinol improves endothelial dysfunction in chronic heart failure. Circulation 2002, 106:221-226.
30. Heunks L.M.A., Vina J., van Herwaarden C.L.A., Folgering H.T.M., Gimeno A., Dekhuijzen P.N.R. Xanthine oxidase is involved in exercise-induced oxidative stress in chronic obstructive pulmonary disease. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology 1999, 277:R1697-R1704.
31. Ball E.G. Xanthine oxidase: purification and properties. Journal of Biological Chemistry 1939, 128:51-67.
32. Cheung K.J., Tzameli I., Pissios P., Rovira I., Gavrilova O., Ohtsubo T., Chen Z., Finkel T., Flier J.S., Friedman J.M. Xanthine oxidoreductase is a regulator of adipogenesis and PPARgamma activity. Cell Metabolism 2007, 5:115-128.
33. Ohtsubo T., Rovira I.I., Starost M.F., Liu C., Finkel T. Xanthine oxidoreductase is an endogenous regulator of Cyclooxygenase-2. Circulation Research 2004, 95:1118-1124.
34. Takano Y., Hase-Aoki K., Horiuchi H., Zhao L., Kasahara Y., Kondo S., Becker M.A. Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sciences 2005, 76:1835-1847.
35. Malik U.Z., Hundley N.J., Romero G., Radi R., Freeman B.A., Tarpey M.M., Kelley E.E. Febuxostat inhibition of endothelial-bound XO: implications for targeting vascular ROS production. Free Radical Biology & Medicine 2011, 51:179-184.
36. Godber B.L.J., Doel J.J., Sapkota G.P., Blake D.R., Stevens C.R., Eisenthal R., Harrison R. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. Journal of Biological Chemistry 2000, 275:7757-7763.
37. Millar T.M., Stevens C.R., Benjamin N., Eisenthal R., Harrison R., Blake D.R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Letters 1998, 427:225-228.
38. Li H., Samouilov A., Liu X., Zweier J.L. Characterization of the magnitude and kinetics of xanthine oxidase-catalyzed nitrite reduction. Evaluation of its role in nitric oxide gereration in anoxic tissues. Journal of Biological Chemistry 2001, 276:24482-24489.
39. Maia L.B., Moura J.J. Nitrite reduction by xanthine oxidase family enzymes: a new class of nitrite reductases. Journal of Biological Inorganic Chemistry 2011, 16:443-460.
40. Li H., Samouilov A., Liu X., Zweier J.L. Characterization of the effects of oxygen on xanthine oxidase-mediated nitric oxide formation. Journal of Biological Chemistry 2004, 279:16939-16946.
41. Alef M.J., Vallabhaneni R., Carchman E., Morris S.M., Shiva S., Wang Y., Kelley E.E., Tarpey M.M., Gladwin M.T., Tzeng E., Zuckerbraun B.S. Nitrite-generated NO circumvents dysregulated arginine/NOS signaling to protect against intimal hyperplasia in Sprague-Dawley rats. Journal of Clinical Investigation 2011, 121:1646-1656.
42. Samal A.A., Honavar J., Brandon A., Bradley K.M., Doran S., Liu Y., Dunaway C., Steele C., Postlethwait E.M., Squadrito G.L., Fanucchi M.V., Matalon S., Patel R.P. Administration of nitrite after chlorine gas exposure prevents lung injury: effect of administration modality. Free Radical Biology & Medicine 2012, 53:1431-1439.
43. Pickerodt P.A., Emery M.J., Zarndt R., Martin W., Francis R.C., Boemke W., Swenson E.R. Sodium nitrite mitigates ventilator-induced lung injury in rats. Anesthesiology 2012, 117:592-601.
44. Baker J.E., Su J., Fu X., Hsu A., Gross G.J., Tweddell J.S., Hogg N. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. Journal of Molecular and Cellular Cardiology 2007, 43:437-444.
45. Zuckerbraun B.S., Shiva S., Ifedigbo E., Mathier M.A., Mollen K.P., Rao J., Bauer P.M., Choi J.J., Curtis E., Choi A.M., Gladwin M.T. Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation. Circulation 2010, 121:98-109.
46. Sugimoto R., Okamoto T., Nakao A., Zhan J., Wang Y., Kohmoto J., Tokita D., Farver C.F., Tarpey M.M., Billiar T.R., Gladwin M.T., McCurry K.R. Nitrite reduces acute lung injury and improves survival in a rat lung transplantation model. American Journal of Transplantation 2012, 12:2938-2948.
47. Tripatara P., Patel N.S., Webb A., Rathod K., Lecomte F.M., Mazzon E., Cuzzocrea S., Yaqoob M.M., Ahluwalia A., Thiemermann C. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. Journal of the American Society of Nephrology 2007, 18:570-580.
48. Webb A., Bond R., McLean P., Uppal R., Benjamin N., Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proceedings of the National Academy of Sciences USA 2004, 101:13683-13688.
49. Lu P., Liu F., Yao Z., Wang C.Y., Chen D.D., Tian Y., Zhang J.H., Wu Y.H. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury. Hepatobiliary & Pancreatic Diseases International 2005, 4:350-355.
50. Huang L., Borniquel S., Lundberg J.O. Enhanced xanthine oxidoreductase expression and tissue nitrate reduction in germ free mice. Nitric Oxide 2010, 22:191-195.
51. Fridovich I. and Handler P., Xanthine oxidase. V. Differential inhibition of the reduction of various electron acceptors., J Biol Chem., 237:916-21, 1962.
52. Millar T.M., Stevens C.R., Benjamin N., Eisenthal R., Harrison R., Blake D.R. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Letters 1998, 427:225-228.
53. Cantu-Medellin N., Kelley E.E. Xanthine oxidoreductase-catalyzed reduction of nitrite to nitric oxide: insights regarding where, when and how. Nitric Oxide 2013, in press. 10.1016/j.niox.2013.02.081.